(Total Views: 692)
Posted On: 07/03/2020 10:59:56 PM
Post# of 149012
Re: Riztheinvestor #40847
Samsung is scheduled to deliver 1.5 million vials, enough for 375,000 patients, in 2020, starting with 125,000 vials in July.
That will be sufficient for financial success for CYDY, although rationing of leronlimab could cause serious problems for many.
I think the only manufacturing risk at this point is Samsung delivery.
That will be sufficient for financial success for CYDY, although rationing of leronlimab could cause serious problems for many.
I think the only manufacturing risk at this point is Samsung delivery.
(0)
(0)Scroll down for more posts ▼
